Use this URL to cite or link to this record in EThOS: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.817860
Title: The roles and control of CD4+ effector and regulatory T cells in biliary autoimmunity
Author: Webb, Gwilym James
ISNI:       0000 0004 9358 6310
Awarding Body: University of Birmingham
Current Institution: University of Birmingham
Date of Award: 2019
Availability of Full Text:
Access from EThOS:
Access from Institution:
Abstract:
Autoimmunity represents a misdirection of the adaptive immune response against the self. The pre- valence of human autoimmunity is increasing, including an increasing prevalence of autoimmune liver disease. Novel therapeutic options are required and failure of the regulation of CD4+ T cells has been implicated in pathogenesis. OX40, ligated by OX40L, is a secondary co-stimulatory molecule which promotes activation and survival of CD4+ T cells and has been proposed as a therapeutic target in autoimmunity and regulatory failure. Complete deficiency in FOXP3-positive regulatory T cells results in a lymphocytic hepatitis associated with autoantibodies and loss of effector CD4+ T cell control. This thesis confirms this finding and demonstrates similar pathology in mice deficient in the regulatory molecule CTLA4 and in Roquin sanroque mutant mice. Each of these mouse models is shown to hyperexpress OX40 on liver-infiltrating CD4+ T cells. In FOXP3 deficiency, blockade of OX40-OX40L interactions abrogates hepatitis; whereas in CTLA4 deficiency and the Roquin sanroque mutant mouse, OX40-OX40L blockade is ineffective. Complementary to these findings, increased expression of OX40 is demonstrated in human autoim- mune liver disease, and a negative regulatory mechanism on the expression of OX40L by T cells by the action of gamma-chain cytokines including interleukin-2 is described.
Supervisor: Not available Sponsor: MRC ; NIHR
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.817860  DOI: Not available
Keywords: R Medicine (General)
Share: